CROWDSTRIKE HOLDINGS INC - A (CRWD)

US22788C1053 - Common Stock

350.15  -3.14 (-0.89%)

Premarket: 348.44 -1.71 (-0.49%)

Fundamental Rating

5

Overall CRWD gets a fundamental rating of 5 out of 10. We evaluated CRWD against 279 industry peers in the Software industry. CRWD has only an average score on both its financial health and profitability. CRWD is valued quite expensive, but it does show an excellent growth. With these ratings, CRWD could be worth investigating further for growth investing!.



5

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
In the past year CRWD had a positive cash flow from operations.
CRWD had negative earnings in 4 of the past 5 years.
Each year in the past 5 years CRWD had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.36%, CRWD is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
CRWD has a Return On Equity of 5.97%. This is in the better half of the industry: CRWD outperforms 73.12% of its industry peers.
With a decent Return On Invested Capital value of 0.95%, CRWD is doing good in the industry, outperforming 65.59% of the companies in the same industry.
Industry RankSector Rank
ROA 2.36%
ROE 5.97%
ROIC 0.95%
ROA(3y)-2.93%
ROA(5y)-4.45%
ROE(3y)-10.51%
ROE(5y)-12.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CRWD has a Profit Margin of 4.84%. This is in the better half of the industry: CRWD outperforms 70.25% of its industry peers.
CRWD has a Operating Margin of 1.65%. This is in the better half of the industry: CRWD outperforms 65.59% of its industry peers.
CRWD has a better Gross Margin (75.37%) than 68.10% of its industry peers.
CRWD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) 4.84%
GM 75.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y2.95%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRWD is destroying value.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
CRWD has more shares outstanding than it did 5 years ago.
CRWD has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 12.58 indicates that CRWD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 12.58, CRWD belongs to the best of the industry, outperforming 86.74% of the companies in the same industry.
CRWD has a debt to FCF ratio of 0.67. This is a very positive value and a sign of high solvency as it would only need 0.67 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.67, CRWD is doing good in the industry, outperforming 77.42% of the companies in the same industry.
A Debt/Equity ratio of 0.26 indicates that CRWD is not too dependend on debt financing.
CRWD's Debt to Equity ratio of 0.26 is on the low side compared to the rest of the industry. CRWD is outperformed by 60.22% of its industry peers.
Even though the debt/equity ratio score it not favorable for CRWD, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.67
Altman-Z 12.58
ROIC/WACC0.08
WACC11.83%

2.3 Liquidity

A Current Ratio of 1.90 indicates that CRWD should not have too much problems paying its short term obligations.
CRWD's Current ratio of 1.90 is in line compared to the rest of the industry. CRWD outperforms 57.35% of its industry peers.
CRWD has a Quick Ratio of 1.90. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Quick ratio (1.90) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.56%, which is quite impressive.
CRWD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 127.96% yearly.
The Revenue has grown by 33.07% in the past year. This is a very strong growth!
CRWD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 65.01% yearly.
EPS 1Y (TTM)71.56%
EPS 3Y127.96%
EPS 5YN/A
EPS Q2Q%40.54%
Revenue 1Y (TTM)33.07%
Revenue growth 3Y51.75%
Revenue growth 5Y65.01%
Sales Q2Q%31.74%

3.2 Future

CRWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.42% yearly.
The Revenue is expected to grow by 28.07% on average over the next years. This is a very strong growth
EPS Next Y20.16%
EPS Next 2Y18.94%
EPS Next 3Y22.01%
EPS Next 5Y34.42%
Revenue Next Year27.77%
Revenue Next 2Y25.01%
Revenue Next 3Y24.03%
Revenue Next 5Y28.07%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 93.62, which means the current valuation is very expensive for CRWD.
CRWD's Price/Earnings ratio is in line with the industry average.
CRWD is valuated expensively when we compare the Price/Earnings ratio to 28.68, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 80.36, which means the current valuation is very expensive for CRWD.
CRWD's Price/Forward Earnings ratio is in line with the industry average.
CRWD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.58.
Industry RankSector Rank
PE 93.62
Fwd PE 80.36

4.2 Price Multiples

CRWD's Enterprise Value to EBITDA ratio is in line with the industry average.
CRWD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 77.43
EV/EBITDA 344.03

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRWD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CRWD's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)4.64
PEG (5Y)N/A
EPS Next 2Y18.94%
EPS Next 3Y22.01%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (11/20/2024, 8:15:12 PM)

Premarket: 348.44 -1.71 (-0.49%)

350.15

-3.14 (-0.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap85.83B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 93.62
Fwd PE 80.36
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 5.97%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.65%
PM (TTM) 4.84%
GM 75.37%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)71.56%
EPS 3Y127.96%
EPS 5Y
EPS Q2Q%
EPS Next Y20.16%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)33.07%
Revenue growth 3Y51.75%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y